JP2013507954A5 - - Google Patents

Download PDF

Info

Publication number
JP2013507954A5
JP2013507954A5 JP2012535105A JP2012535105A JP2013507954A5 JP 2013507954 A5 JP2013507954 A5 JP 2013507954A5 JP 2012535105 A JP2012535105 A JP 2012535105A JP 2012535105 A JP2012535105 A JP 2012535105A JP 2013507954 A5 JP2013507954 A5 JP 2013507954A5
Authority
JP
Japan
Prior art keywords
cancer cells
pharmaceutical composition
peptides
seq
nos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012535105A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013507954A (ja
JP5751519B2 (ja
Filing date
Publication date
Priority claimed from KR1020090101003A external-priority patent/KR101061017B1/ko
Application filed filed Critical
Publication of JP2013507954A publication Critical patent/JP2013507954A/ja
Publication of JP2013507954A5 publication Critical patent/JP2013507954A5/ja
Application granted granted Critical
Publication of JP5751519B2 publication Critical patent/JP5751519B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012535105A 2009-10-23 2010-08-24 白血球の血管外遊出またはガン細胞の成長及び／もしくは転移を抑制するポリペプチドまたはその融合蛋白質 Active JP5751519B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2009-0101003 2009-10-23
KR1020090101003A KR101061017B1 (ko) 2009-10-23 2009-10-23 암세포의 성장 및/또는 전이 억제용 약학 조성물
PCT/KR2010/005619 WO2011049289A2 (ko) 2009-10-23 2010-08-24 백혈구의 혈관외유출 또는 암세포의 성장 및/또는 전이를 억제하는 폴리펩타이드 또는 그의 융합 단백질

Publications (3)

Publication Number Publication Date
JP2013507954A JP2013507954A (ja) 2013-03-07
JP2013507954A5 true JP2013507954A5 (enExample) 2014-08-07
JP5751519B2 JP5751519B2 (ja) 2015-07-22

Family

ID=43900764

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012535105A Active JP5751519B2 (ja) 2009-10-23 2010-08-24 白血球の血管外遊出またはガン細胞の成長及び／もしくは転移を抑制するポリペプチドまたはその融合蛋白質

Country Status (6)

Country Link
US (1) US8530421B2 (enExample)
EP (2) EP2491944A4 (enExample)
JP (1) JP5751519B2 (enExample)
KR (1) KR101061017B1 (enExample)
CN (1) CN102711792A (enExample)
WO (1) WO2011049289A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0689637B2 (ja) 1990-08-28 1994-11-09 株式会社荏原製作所 トンネル微気圧波低減装置
KR101644982B1 (ko) * 2015-07-23 2016-08-02 주식회사 엔솔바이오사이언스 신규 펩타이드 및 그 용도
EP4268892B1 (en) * 2016-03-02 2025-01-29 University of Pittsburgh- Of the Commonwealth System of Higher Education Matrix bound nanovesicles and their use
US20200095296A1 (en) * 2017-06-05 2020-03-26 The Trustees Of Columbia University In The City Of New York Use of peptides as biomarkers in the diagnosis, confirmation and treatment of a neurological disorder and tcr and/or hla immunoprofiling in neurodegenerative disease
KR102268921B1 (ko) * 2019-12-10 2021-06-23 강원대학교산학협력단 p53을 활성화하는 펩타이드를 포함하는 조성물
US20230023726A1 (en) * 2019-12-11 2023-01-26 Supadelixir Inc. Pharmaceutical composition comprising peptide that inhibits interaction of p53 and foxo4
KR20230033097A (ko) * 2021-08-27 2023-03-08 (주)티카로스 기능이 강화된 신규 키메라 항원 수용체(car)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541087A (en) * 1994-09-14 1996-07-30 Fuji Immunopharmaceuticals Corporation Expression and export technology of proteins as immunofusins
DE69840509D1 (de) * 1997-09-30 2009-03-12 Peviva Ab Apoptose-bezogene verbindungen und deren verwendung
WO2000032235A1 (de) * 1998-11-26 2000-06-08 Pentapharm Ag Transportsystemkonjugate
US6451969B1 (en) * 1999-01-15 2002-09-17 The Burnham Institute Methods for inhibiting tumor metastasis, and peptides useful therfor
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
GB9911683D0 (en) * 1999-05-19 1999-07-21 Chiron Spa Antigenic peptides
CA2402530C (en) * 2000-03-13 2014-01-14 Cornell Research Foundation, Inc. Blocking leukocyte emigration and inflammation by interfering with cd99
CH694935A5 (de) * 2000-07-26 2005-09-30 Straumann Holding Ag Oberflaechenmodifizierte Implantate.
US7460960B2 (en) * 2002-05-10 2008-12-02 Epitome Biosystems, Inc. Proteome epitope tags and methods of use thereof in protein modification analysis
CA2496242A1 (en) * 2002-08-21 2004-03-04 Merck Patent Gesellschaft Mit Beschraenkter Haftung T-cell epitopes in staphylococcal enterotoxin b
US7385027B2 (en) * 2003-01-07 2008-06-10 University Of Kentucky Research Foundation Membrane-permeable peptide capable of calpain inhibition
WO2005074986A2 (en) * 2004-02-10 2005-08-18 Genobiotix Aps Bioactive species capable of interfering with a microbial toxin-antitoxin complex and methods for evaluation and use of said bioactive species
WO2007005898A2 (en) 2005-07-05 2007-01-11 Cornell Research Foundation, Inc. Blocking leukocyte emigration and inflammation by interfering with cd99l2
KR100793947B1 (ko) * 2006-06-30 2008-01-16 강원대학교산학협력단 암세포의 성장 및 전이 억제 활성을 갖는 폴리펩타이드또는 그의 융합 단백질
WO2007037601A1 (en) 2005-09-28 2007-04-05 Knu-Industry Cooperation Foundation Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof
KR100793949B1 (ko) * 2006-07-19 2008-01-16 강원대학교산학협력단 염증 질환의 예방 또는 치료 활성을 갖는 폴리펩타이드또는 그의 융합 단백질
KR100941678B1 (ko) * 2007-12-17 2010-02-12 강원대학교산학협력단 암세포의 전이 억제 활성을 갖는 폴리펩타이드 또는 그의융합 단백질
KR101074005B1 (ko) * 2009-02-26 2011-10-17 재단법인춘천바이오산업진흥원 백혈구의 혈관외유출 억제 활성을 갖는 폴리펩타이드 또는 그의 융합 단백질

Similar Documents

Publication Publication Date Title
JP2013507954A5 (enExample)
EA201400173A1 (ru) Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
EA201400172A1 (ru) Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
WO2017044894A3 (en) Cartilage-homing peptides
JP2009286795A5 (enExample)
BR112012016853A2 (pt) "composições farmacêuticas para administração oral de peptídeos de insulina".
MX383982B (es) Inmunoglobulinas portadoras y usos de las mismas.
WO2013066839A3 (en) Compounds and methods
WO2013066835A3 (en) Compounds and methods
NZ602557A (en) Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
IN2012DN03043A (enExample)
MX345928B (es) Composiciones terapeuticamente activas y metodos de uso de las mismas.
WO2011084991A3 (en) Fluorinated hdac inhibitors and uses thereof
MX2013008478A (es) 1, 4 riazepinas/sulfonas como inhibidores de beta secretasa 1 (base1) y/o beta secretasa 2 (bace2).
NI201100155A (es) Composiciones y métodos para el tratamiento prolongado con aminopiridinas
MX385898B (es) Moleculas de fusion derivadas de la toxina colix para suministro oral de una carga biologicamente activa.
JP2014529399A5 (enExample)
JP2015514778A5 (enExample)
WO2011038933A3 (en) Anti-hsv antibody
JO3434B1 (ar) مركبات صيدلانية لمعالجة السرطان وامراض واضطرابات اخري
EP2560642A4 (en) TREATMENT OF GICHT
UA100127C2 (ru) Пептид cdh3 и лекарственное средство, содержащее его
NZ602845A (en) Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
JP2015533791A5 (enExample)
JP2018048151A5 (enExample)